Drugs Made in America Ac-RTSDMAARPreferred / convertible

13F holders, Q2 2025 (June 30)
24holders +5
6new positions
1sold out
$0.12avg. 13F price*

At the end of Q2 2025, 24 institutions reported holding Drugs Made in America Ac-RTS (DMAAR) in their 13F filings, up 5 from Q1 2025. 6 opened new positions and 1 sold out. The largest holders were Toronto Dominion Bank ($234K), Polar Asset Management Partners Inc. ($228K) and Hudson Bay Capital Management LP ($225K).

Company
Drugs Made in America Ac-RTS
CUSIP
G2847J112
Latest filing quarter
Q2 2026

History

Number of 13F holders

010203040 Q1 2025: 19Q1 2025Q2 2025: 24Q2 2025Q3 2025: 32Q3 2025Q4 2025: 32Q4 2025Q1 2026: 35Q1 2026Q2 2026: 28Q2 2026

Total Exit/New Position Q1 2025 → Q2 2025

InstitutionsTotal Value
New Positions6$465K
Exits1$2K

All 13F filers, Q1 2025 → Q2 2025: 4,158,783 shares bought and 32,609 shares sold, net +4,126,174 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 24 holders
Toronto Dominion Bank — New 1,945,600 $234K
Polar Asset Management Partners Inc. — No change 1,900,000 $228K
Hudson Bay Capital Management LP — No change 1,800,000 $225K
Harraden Circle Investments, LLC — No change 1,500,000 $180K
Glazer Capital, LLC — No change 1,300,000 $156K
Aristeia Capital, L.L.C. — Reduce -1.4% 887,834 $107K
Highbridge Capital Management LLC — No change 850,000 $106K
Crossingbridge Advisors, LLC — No change 850,000 $106K
Mangrove Partners Im, LLC — No change 850,000 $102K
Clear Street LLC — Add +22.2% 672,087 $81K
Heights Capital Management, Inc. — New 633,816 $79K
Wolverine Asset Management LLC — Reduce -0.3% 601,038 $72K
Boothbay Fund Management, LLC — New 570,000 $69K
Atw Spac Management LLC — No change 570,000 $69K
AQR Arbitrage LLC — No change 500,000 $62K
Westchester Capital Management, LLC — New 500,000 $62K
Cantor Fitzgerald, L. P. — No change 500,000 $60K
LMR Partners LLP — No change 500,000 $60K
Schonfeld Strategic Advisors LLC — Add +107.3% 414,492 $50K
Whitebox Advisors LLC — No change 400,000 $48K
Mizuho Securities USA LLC — — 209,897 $21K
Quarry LP — No change 150,000 $18K
Verition Fund Management LLC — New 100,000 $12K
Bulldog Investors, LLP — New 72,964 $9K

"% of holder's portfolio" is DMAAR's weight in each manager's 13F, not the share of Drugs Made in America Ac-RTS the manager owns.